Search Results for: Microfluidic Modulation Spectroscopy MMS For
Articles
Microfluidic Modulation Spectroscopy (MMS) For Protein Therapeutic Drug Analysis August 5, 2018
Automated, high sensitivity spectroscopic analyses for the development, formulation and manufacture of biotherapeutics are now available thanks to RedShiftBio’s new AQS3pro protein characterization platform. The system is based on Microfluidic Modulation Spectroscopy (MMS) technology. Read this application note to learn about how MMS characterizes higher order protein structures, the mechanisms of protein stability, aggregation, protein similarity and quantitation.
CHARACTERIZATION CORNER - From Dilute Sample to Clinically Representative Formulation: Analyzing the Higher Order Structure of mAbs Over a Wide Dynamic Range February 28, 2019
Jeff Zonderman explains how the characterization of mAbs at high concentration in clinically representative formulations, without the need for dilution or concern for interference from a formulation buffer’s excipient, is vital.
RedShiftBio Launches New Protein Characterization Instrument System June 6, 2018
RedShift™ BioAnalytics, Inc. (RedShiftBio™) unveiled the AQS3™pro, a new protein characterization platform with powerful, integrated bioanalytics software that delivers automated, high sensitivity spectroscopic analysis for the development, formulation and manufacture of biotherapeutics.
RedShiftBio Announces Collaboration Trial Completion March 26, 2018
RedShift BioAnalytics, Inc. (RedShiftBio), a provider of analytical instrumentation for the characterization of protein therapeutics, recently announced the completion of...
